Raffaele Giusti: MARIPOSA overall survival data at ELCC25
Mar 28, 2025, 20:11

Raffaele Giusti: MARIPOSA overall survival data at ELCC25

Raffaele Giusti, Medical director at Azienda Ospedaliera Sant’Andrea, shared on X:

“MARIPOSA OS data at ELCC25. While the combination offers a statistically significant OS advantage, the absolute clinical benefit is disappointingly modest.

Should more always mean better? Or should we be striving for smarter, not just stronger, strategies?”